Novavax initiated PREVENT-19 pivotal phase 3 efficacy trial of COVID-19 vaccine in the US and Mexico
On Dec. 28, 2020, Novavax announced initiation of PREVENT-19, its pivotal Phase 3 study in the U.S. and…
On Dec. 28, 2020, Novavax announced initiation of PREVENT-19, its pivotal Phase 3 study in the U.S. and…
On Dec. 28, 2020, Soligenix announced that the National Institute of Allergy and Infectious Diseases (NIAID), had awarded…
On Dec. 24, 2020, AIM ImmunoTech announced that the post-COVID-19 モLong Haulerï¾” portion of the active AMP-511 Expanded…
On Dec. 24, 2020, Inovio Pharmaceuticals announced publication of peer-reviewed Phase 1 clinical data from the first cohort…
On Dec. 23, 2020, Quidel announced that it had received Emergency Use Authorization (EUA) from the FDA to…
On Dec. 23, 2020, Serum Institute of India and Dynavax jointly announced that the first participants had been…
On Dec. 23, 2020, Moderna announced that Health Canada had authorized its vaccine against COVID-19 for the immunization…
On Dec. 23, 2020, Altimmune announced that the FDA had issued a clinical hold on the Companyï¾’s Investigational…
On Dec. 23, 2020, Pfizer and BioNTech announced a second agreement with the U.S. government to supply an…
On Dec. 22, 2020, Resverlogix announced published findings in the Proceedings of the National Academy of Sciences (PNAS),…
On Dec. 22, 2020, the NIH researchers announced that three clinical trial platforms working together to test the…
On Dec. 22, 2020, Sorrento Therapeutics announced that an Emergency Use Authorization (EUA) Application had been submitted to…
On Dec. 22, 2020, a phase II clinical trial of a treatment for COVID-19 patients was started at…
On Dec. 22, 2020, RedHill Biopharma announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva, ABC294640)1…
On Dec. 22, 2020, the ACIP updated interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be…
On Dec. 22, 2020, Cocrystal Pharma announced the selection of CDI-45205 as the lead compound for further development…
On Dec. 21, 2020, CureVac announced that the first participant in a clinical Phase 3 study with its…
On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…
On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…
On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…
On Dec. 21, 2020, the WHO reported that authorities of the United Kingdom of Great Britain and Northern…
On Dec. 21, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that it had begun COVID-19 vaccinations…
On Dec. 21, 2020, Quidel announced that it had received Emergency Use Authorization from the FDA to market…
On Dec. 21, 2020, Innovation Pharma announced that the FDA had approved the Companyï¾’s Investigational New Drug (IND)…
On Dec. 21, 2020, Innovation Pharmaceuticals announced that the FDA had approved the Companyï¾’s Investigational New Drug (IND)…
On Dec. 21, 2020, LabCorp and Walgreens announced that the Pixel by Labcorpï¾™ At-Home COVID-19 Collection Kit is…
On Dec. 21, 2020, Novan announced it had entered into a Master Services Agreement (MSA) with Catalent, which…
On Dec. 21, 2020, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Dec. 21, 2020, Pfizer and BioNTech announced that the European Commission (EC) had granted a conditional marketing…
On Dec. 19, 2020, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of…